Internal Medicine, Hematology & Oncology · Baltimore, MD
NPI
1932134814
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
600 N Wolfe St
Baltimore, MD, 21287
Phone (410) 955-3142
Groups this clinician bills Medicare through
Medicare paid, 2024
$39K
406 services
Medicare patients, 2024
224
Average age 70
Drug cost, 2024
$1.9M
1,386 prescriptions
Company payments, 2024
$3,025
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Streiff was code 99215 (office e&m - established), 94 times for 63 patients. In total Michael Streiff billed 406 services in 19 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 94 | 63 | $112.51 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 15 | $62.68 | $2,821 |
| 99215 Office E&M - Established | Office | 45 | 36 | $133.19 | $5,994 |
| 99214 Office E&M - Established | Office | 41 | 34 | $93.25 | $3,823 |
| 99223 Hospital E&M - Initial | Facility | 24 | 24 | $140.68 | $3,376 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 21 | 18 | $13.37 | $281 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 18 | 18 | $13.35 | $240 |
| 99233 Hospital E&M - Subsequent | Facility | 17 | 11 | $96.11 | $1,634 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $106.38 | $1,702 |
| 99205 Office E&M - New | Facility | 15 | 15 | $138.70 | $2,081 |
| 99213 Office E&M - Established | Office | 13 | 12 | $68.39 | $889 |
| 99214 Office E&M - Established | Facility | 11 | 11 | $76.34 | $840 |
By year: 2022 $36K for 463 services; 2023 $33K for 328 services; 2024 $39K for 406 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Streiff prescribed most often to Medicare patients was Warfarin Sodium, with 686 prescriptions and refills. In total Michael Streiff wrote 1,386 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Warfarin Sodium Generic | 686 | 971 | 114 | $5,435 |
| Eliquis Apixaban | 170 | 259 | 31 | $144K |
| Xarelto Rivaroxaban | 73 | 165 | 19 | $89K |
| Enoxaparin Sodium Generic | 71 | 75 | 28 | $19K |
| Jantoven Warfarin Sodium | 45 | 59 | Under 11 | $195 |
| Tranexamic Acid Generic | 31 | 31 | 17 | $1,177 |
| Besremi Ropeginterferon Alfa-2b-Njft | 31 | 31 | Under 11 | $494K |
| Jakafi Ruxolitinib Phosphate | 16 | 16 | Under 11 | $191K |
| Oxycodone Hcl Generic | 14 | 14 | Under 11 | $62.25 |
| Promacta Eltrombopag Olamine | 13 | 18 | Under 11 | $91K |
| Morphine Sulfate Er Morphine Sulfate | 12 | 12 | Under 11 | $1,101 |
| Exjade Deferasirox | 12 | 12 | Under 11 | $284K |
| Hydromorphone Hcl Generic | 12 | 12 | Under 11 | $300 |
| Morphine Sulfate Generic | 12 | 12 | Under 11 | $1,219 |
| Fondaparinux Sodium Generic | 12 | 20 | Under 11 | $19K |
Brand drugs: 406 claims; generic drugs: 980 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Michael Streiff $3,025 ($3,025 in general payments such as food, travel and fees) from 1 company. The largest payer was CSL Behring with $3,025.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 3 | $3,025 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.